BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
AlphaGraphs

UnitedHealth might turn suitor for Tenet’s Conifer unit

UnitedHealth Group (UNH), a diversified healthcare company, has been named as a possible suitor in the sale of Tenet Healthcare’s (THC) Conifer unit. If a deal takes place between the two firms, analysts expect Tenet to value its wholly owned operating subsidiary, Conifer Health Solutions to about $2 billion. In 2017, Tenet — under the […]

July 19, 2018 2 min read
AlphaGraphs

UnitedHealth Group (UNH), a diversified healthcare company, has been named as a possible suitor in the sale of Tenet Healthcare’s (THC) Conifer unit. If a deal takes place between the two firms, analysts expect Tenet to value its wholly owned operating subsidiary, Conifer Health Solutions to about $2 billion. In 2017, Tenet — under the […]

UnitedHealth Group (UNH), a diversified healthcare company, has been named as a possible suitor in the sale of Tenet Healthcare’s (THC) Conifer unit. If a deal takes place between the two firms, analysts expect Tenet to value its wholly owned operating subsidiary, Conifer Health Solutions to about $2 billion.

In 2017, Tenet — under the pressure of its largest shareholder Glenview Capital Management — put its healthcare management subsidiary Conifer up for sale. In 2017, Confier accounted for 8% of the total sales. The sale of Conifer is a part of the company’s larger plan of restructuring that includes cutting workforce, divesting hospitals, breaking business segments and cut cost by $100 million by the end of this year.

According to the latest reports by the Wall Street Journal, the insurance giant is one of the companies that is aiming to acquire Tenet’s Conifer unit. There are no details on the other potential suitors. However, there is no certainty that the deal between UnitedHealth and Tenet will be consummated. If it does, Conifer would be a part of UnitedHealth’s fastest growing business Optum.

Related: UnitedHealth Group reports Q2 earnings above estimates

This week, UnitedHealth Group reported its Q2 earnings that topped analyst estimates. It posted a 12% growth in its revenues to $56.1 billion, generating profits of $2.98 per share. Adjusted EPS totaled $3.14 for the quarter. Both GAAP and adjusted EPS grew 28% year-over-year. Despite the strong results, the company’s stock is trading in the red. As of today, the company’s share price is down 0.95% to $252.96.

UnitedHealth Group Q2 Infographic


UnitedHealth second quarter 2018 earnings

ADVERTISEMENT